PD-L1 in the palm of your hand: palmitoylation as a target for immuno-oncology

被引:9
|
作者
von Knethen, Andreas [1 ]
Bruene, Bernhard [1 ]
机构
[1] Goethe Univ Frankfurt, Fac Med, Inst Biochem Pathobiochem 1, Theodor Stern Kai 7, D-60590 Frankfurt, Germany
关键词
D O I
10.1038/s41392-019-0053-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Development of immuno-oncology drugs — from CTLA4 to PD1 to the next generations
    Axel Hoos
    Nature Reviews Drug Discovery, 2016, 15 : 235 - 247
  • [42] Development of immuno-oncology drugs - from CTLA4 to PD1 to the next generations
    Hoos, Axel
    NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (04) : 235 - 247
  • [43] PD1/PD-L1 immunohistochemistry in thoracic oncology: Where are we?
    Hofman, Paul
    Ilie, Marius
    Lassalle, Sandra
    Long, Elodie
    Bence, Coraline
    Butori, Catherine
    Hofman, Veronique
    ANNALES DE PATHOLOGIE, 2017, 37 (01) : 39 - 45
  • [44] CD73-adenosine: a next-generation target in immuno-oncology
    Allard, David
    Allard, Bertrand
    Gaudreau, Pierre-Olivier
    Chrobak, Pavel
    Stagg, John
    IMMUNOTHERAPY, 2016, 8 (02) : 145 - 163
  • [46] Immuno-PET Imaging of Tumour PD-L1 Expression in Glioblastoma
    Sharma, Gitanjali
    Braga, Marta C.
    Da Pieve, Chiara
    Szopa, Wojciech
    Starzetz, Tatjana
    Plate, Karl H.
    Kaspera, Wojciech
    Kramer-Marek, Gabriela
    CANCERS, 2023, 15 (12)
  • [47] Focus on PD-1/PD-L1 as a Therapeutic Target in Ovarian Cancer
    Dumitru, Adrian
    Dobrica, Elena-Codruta
    Croitoru, Adina
    Cretoiu, Sanda Maria
    Gaspar, Bogdan Severus
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [48] Various Uses of PD1/PD-L1 Inhibitor in Oncology: Opportunities and Challenges
    Li, Zhitao
    Sun, Guoqiang
    Sun, Guangshun
    Cheng, Ye
    Wu, Liangliang
    Wang, Qian
    Lv, Chengyu
    Zhou, Yichan
    Xia, Yongxiang
    Tang, Weiwei
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [49] A Systematic Review of the Tumor-Infiltrating CD8+ T-Cells/PD-L1 Axis in High-Grade Glial Tumors: Toward Personalized Immuno-Oncology
    Shadbad, Mahdi Abdoli
    Asadzadeh, Zahra
    Hosseinkhani, Negar
    Derakhshani, Afshin
    Alizadeh, Nazila
    Brunetti, Oronzo
    Silvestris, Nicola
    Baradaran, Behzad
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [50] ASPH, a focal target in immuno-oncology for therapeutic cancer vaccine and cell therapy development
    Csiki, Ildiko
    Fuller, Steve
    Lebowitz, Michael
    Ghanbari, Hossein
    Celebi, John
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18